Clayton Hardman

Title: Innovations of Clayton Hardman

Introduction

Clayton Hardman is a notable inventor based in Stanford, California. He has made significant contributions to the field of chemistry, particularly in the development of bryostatin compounds. With a total of three patents to his name, Hardman's work is recognized for its potential impact on clinical applications.

Latest Patents

One of Hardman's latest patents focuses on bryostatin compounds and methods of preparing the same. The methods provided allow for the preparation of bryostatin 1 in multi-gram quantities using a low and unprecedented number of convergent synthetic steps from commercially available materials. These methods are scalable and have low estimated material costs, making it feasible to produce enough material to meet clinical needs. Additionally, the patent includes a variety of bryostatin analog compounds and prodrug forms that can be synthesized using these methods, along with pharmaceutical compositions that incorporate them.

Career Highlights

Clayton Hardman is affiliated with Leland Stanford Junior University, where he conducts his research and development work. His innovative approaches to synthesizing bryostatin compounds have garnered attention in the scientific community.

Collaborations

Hardman has collaborated with esteemed colleagues such as Paul A. Wender and Ryan Quiroz, contributing to the advancement of research in his field.

Conclusion

Clayton Hardman's work exemplifies the intersection of innovation and practical application in the realm of chemistry. His contributions to bryostatin compounds hold promise for future clinical advancements.